Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
Open accessThe DOI matches its Crossref record; 98 of the 99 references it cites were found in a registry or an index.
Abstract
Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benzodiazepines long-term without ever receiving evidence-based first-line treatments (e.g., psychotherapy, relaxation techniques, sleep hygiene education, serotonergic agents). This review discusses the risks and benefits of, and alternatives to benzodiazepines. We discuss evidence-based indications and contraindications, and the theoretical biopsychosocial bases for effectiveness, ineffectiveness and harm. Potential adverse effects and drug-drug interactions are summarized. Finally, both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed. Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Benzodiazepines are commonly prescribed for anxiety and insomnia but are often misused for their sedative effects [64, 65].”
From Prevalence and patterns of substance use in West Africa: A systematic review and meta-analysis (2024) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
Neurobiologic advances from the brain disease model of addiction
Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1511480 · Cited by 2,008
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943 · cited 10×
“However, the study [21] acknowledged the difficulty prescribers face when they “inherit” patients who previously received BZDs from other prescribers (many of whom started BZDs prior to CPGs), creating “an immediate tension” as providers attempt to balance individual patient factors with the need to provide evidence-ba…”
BackgroundInfluentialSateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519 · cited 9×
“However, the study [21] acknowledged the difficulty prescribers face when they “inherit” patients who previously received BZDs from other prescribers (many of whom started BZDs prior to CPGs), creating “an immediate tension” as providers attempt to balance individual patient factors with the need to provide evidence-ba…”
BackgroundInfluentialOpioid-induced Hyperalgesia: A Qualitative Systematic Review
Angst, M. S., & Clark, J. D. (2006) · Anesthesiology · doi:10.1097/00000542-200603000-00025 · Cited by 1,188
Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the Literature
Jacobsen, L. K., Southwick, S. M., & Kosten, T. R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1184 · Cited by 1,041 · cited 1×
“High rates of comorbidity suggest that PTSD and SUDs are functionally related, a concept supported by several studies indicating a pathway (likely related to corticotropin-releasing hormone and norepinephrine) whereby PTSD precedes substance use [69].”
BackgroundFava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927 · cited 1×
“These “antidepressants” (that are not only effective for depression) typically take four to six weeks before they exert clinical effect, though in the treatment of anxiety symptoms this delay can be even longer [30].”
BackgroundComparative Meta-Analysis of Pharmacotherapy and Behavior Therapy for Persistent Insomnia
Smith, M. T., Perlis, M. L., Park, A., Smith, M. S., Pennington, J., Giles, D. E., & Buysse, D. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.5 · Cited by 863 · cited 2×
“…SAD and insomnia, BZDs are frequently overprescribed for other indications for which there is no evidence of efficacy, to individuals who have contraindicated comorbid conditions, for longer periods of time than are recommended, and before other first and second-line treatments are tried [52–57].”
BackgroundBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Research works printed but not linked: 7
- Pary R. Lewis S. Prescribing benzodiazepines in clinical practice Resid. Staff Phys. 2008 54 8 17
- National Institute for Health and Care Excellence (NICE) Generalised Anxiety Disorder and Panic Disorder in Adults: Management 2011 Available online: https://www.nice.org.uk/guidance/cg113 (accessed on 25 October 2017) 31961629
- Stahl S.M. Essential Psychopharmacology 4th ed. Cambridge New York, NY, USA 2013
- Powers M. Becker E. Gorman J. Kissen D. Smits J. Anxiety and Depression Association of America Clinical Practice Review for GAD 2015 Available online: https:/adaa.org (accessed on 20 October 2017)
- Foa E.B. Keane T.M. Friedman M.J. Cohen J.A. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies 2nd ed. Guilford Press New York, NY, USA 2009 566
- Ader R. Psychoneuroimmunology Elsevier Academic Press Burlington, MA, USA 2006
- Yonkers K.A. Spinelli M. Pharmacological issues during pregnancy Psychiatry 3rd ed. Tasman A. Kay J. Lieberman J.A. John Wiley & Sons Chichester, UK 2008 Volume 1 2423 2424
Cited by
Items 201–254 of 254
Knyahnytska, Y., Abbaspour, Z., & Kendzerska, T. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_406-1 · Cited by 1
Sleep Disturbance During an Acute Manic Episode
Allen, M., Gharbaoui, Y., Wu, C., Gawad, N. A., & Gordon, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-59309-4_13
Cervical cancer survivors and health care use: A Danish population-based register study
Skorstengaard, M., Frederiksen, M. E., Baillet, M. V., Beau, A., Jensen, P. T., Rygaard, C., Hallas, J., & Lynge, E. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.02.003
Lee, B. L., Song’En, J. J., Soo, S. C., & Tan, J. H. (2021) · The Singapore Family Physician · doi:10.33591/sfp.47.3.uc1
Jung, Y. Y., Ha, C. M., Jung, S. T., & Lee, H. J. (2020) · Journal of the Korean society of clinical toxicology · doi:10.22537/jksct.2020.18.2.94 · Cited by 1
Benefícios do uso de melatonina no tratamento de pessoas com distúrbios do sono
Carvalho, W. O., & da Paixão, J. A. (2021) · Pubsaúde · doi:10.31533/pubsaude6.a165
“Escribá e Hoyo (2016) realizaram um estudo com 23 pacientes com transtorno de comportamento do sono REM (RBD) com média de idade de 64,7 anos.”
InfluentialTranquilizers/Anxiolytics: Definition, Indications, Contraindications, and Treatment
Kloiber, S. M., & Konstantinou, G. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_59-1
Identification of Risk Factors Associated with Aripiprazole-induced Acute Akathisia
SHIRAHAMA, M., Ishida, S., Nagata, K., Watanabe, H. A., Tsuji, T., Miyazaki, K., & Egashira, N. (2020) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.46.414
Hernesto, M. M., de Andrade, L. D. S. C., carvalho, M. J. S. B., Sanches, I. M., Mourão, L. C., da Trindade, M. C. D. S., Dantas, L. S., & Barradas, K. L. (2021) · Research Society and Development · doi:10.33448/rsd-v10i17.24784 · Cited by 12
Screening of the use of benzodiazepines during COVID-19 pandemic in the general population
Исјановски, В., & Kacarska, M. (2021) · Macedonian Pharmaceutical Bulletin · doi:10.33320/10.33320/maced.pharm.bull.2021.67.01.002
“Benzodiazepines may be tempting at this time because of their "quick fix", but we know that because of this "quick fix", patients are unable to develop coping skills that can cope with stressors (Davydow et al., 2008; Gelpin et al., 1996; Guina and Merrill, 2018; Mellman et al., 1998).”
BackgroundHarmatz, D., Vinker, S., Wagner, T., Raveh, T., Merzon, E., & Golan‐Cohen, A. (2022) · Israel Journal of Health Policy Research · doi:10.1186/s13584-022-00513-0
Comparison of bromazepam and ibuprofen influence on tooth pulp-evoked potentials in humans
Vuković, B., Lazić, Z., Avramov, S., Pavlović, M., Lazić, M. P. Č., Malešević, A., Trifunovic, J., & Nikolić, Ž. (2022) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh220131047v
dos Santos, J. R. B., da Cruz, L. D. M. A., Lopes, L. P. N., & Matheus, M. E. (2022) · Research Society and Development · doi:10.33448/rsd-v11i10.32349
“…risk of secondary accentuation of the use of adjuvant/adjunctive treatments that may have significant adverse effects (anticholinergics, phenothiazine antihistamines, and benzodiazepines); and risk of withdrawal (Wilson & Lader, 2015; Gauthier et al, 2018; Guina & Merrill, 2018; Keks et al., 2019).”
BackgroundKnyahnytska, Y., Abbaspour, Z., & Kendzerska, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_406
Uso de Benzodiazepínicos para tratamento crônico de insônia: revisão integrativa de literatura
Machado, L. D. V., Citadin, M. S., Borges, A. F. F., Santos, G. F. M. D., & Grela, G. F. D. (2023) · Brazilian Journal of Development · doi:10.34117/bjdv9n3-140
Sleep and Circadian Rhythm Disorders
Bisdounis, L., Kyle, S. D., Saunders, K., Hill, E. A., & Espie, C. A. (2023) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197542521.003.0023 · Cited by 1
Moffett, C., Kost, K. J., Thompson, A. L., Pergolizzi, J. V., Jr., Largent‐Milnes, T. M., Raffa, R. B., & Vanderah, T. W. (2023) · Pharmacology & Pharmacy · doi:10.4236/pp.2023.143006
Stalhandske, K. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197559321.003.0048
PERFIL DE CONSUMO DE BENZODIAZEPÍNICOS DURANTE A PANDEMIA DO COVID-19
Barbosa, M. B. M., Pachêco, W. B., da Hora, A. F. L. T., Melo, J. S., & Barros, P. D. T. S. (2023) · Revista Foco · doi:10.54751/revistafoco.v16n6-134 · Cited by 3
Silva, B. E. R., Silva, J. R., & Cé, R. (2023) · Revista Multidisciplinar em Saúde · doi:10.51161/integrar/rems/3807
“Common adverse effects for patients taking alprazolam include drowsiness, tiredness, dizziness, sleep problems (insomnia), memory problems, and poor balance or coordination (GUINA & MERRILL, 2018).”
Prevalence and factors associated with the use of benzodiazepines by health students
Neto, J. C. D. S., Carvalho, I. F., Fausto, N. E. C., Silveira, R. R. P., MOURA, L. S. D. A., & da Cruz, A. F. P. (2023) · Concilium · doi:10.53660/clm-1813-23m31
Behavioural Treatment Considerations for Insomnia: a Review of Meta-analyses
Pal, A., Basu, A., & Gupta, R. M. (2023) · Current Sleep Medicine Reports · doi:10.1007/s40675-023-00264-7
“This group of drugs is considered to be effective in the management of insomnia, though there has been a number of safety concerns that has been expressed by the regulatory authorities [4].”
BackgroundOkulevičiūtė, A., & Sakalauskienė, G. L. (2023) · Acta medica Lituanica · doi:10.15388/amed.2023.30.2.14 · Cited by 1
“…(WHO), BZDs are used as a part of the treatment for several clinical disorders, including panic attacks, various types of epileptic attacks, seizure disorders, depression, anxiety, insomnia, excitation, aggression, phobias, inducing amnesia, alcohol withdrawal, and catatonia [8, 9, 10, 11].”
BackgroundAlmeida, M. A. S. O. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2023.tde-14112023-113313
GABAERGIC MODULATION IN THE FORMATION OF DECLARATIVE MEMORY AND FACE RECOGNITIONPreprint
León, C. S., Celso, A. L., Benítez, F. A. U., Bonilla, M., Olivar, N., Toledo, J., Brusco, L. I., & Forcato, C. (2023) · doi:10.31234/osf.io/dn2c3
Veskimäe, L., Vorobjov, S., & Pärna, K. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-077899 · Cited by 1
Ogbonna, C. I., Fenn, H. H., & Hitching, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-53976-3_7
Non-pharmacological treatment of insomnia in palliative care
Sulerzycki, M., Pomykała, K., Giemza, K., Dumański, S., Kołodziejczyk, K., & Dzierżanowski, T. (2024) · Medycyna Paliatywna · doi:10.5114/pm.2024.141462
Bogowicz, P., Mehta, A., Choudhary, S., Brhlíková, P., Roderick, P., McGettigan, P., Farooqui, H. H., Sharma, A., & Pollock, A. M. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2372089
Introduction to Deprescribing Psychiatric Medications
(2024) · Wiley eBooks · doi:10.1002/9781394291052.mdg001
Safe Deprescribing of Benzodiazepines and Z‐drugs
(2024) · Wiley eBooks · doi:10.1002/9781394291052.mdg003
ABA meets psychopharmacology: The interaction of two methodologies
Valdovinos, M. G., & Wrenn, C. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21769-2.00001-9
Coteur, K., Ryan, C. A., Smith, S. M., Sheaf, G., DeWert, M., Gardner, D. M., & Cadogan, C. A. (2024) · HRB Open Research · doi:10.12688/hrbopenres.13976.1
McLean, C. P., & Rosenfeld, E. A. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009086264.007
Mental health literacy among primary care providers in Hungary: a vignette-based survey
Swisher, V. S., Őri, D., Rihmer, Z., & Wernigg, R. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-024-00539-5 · Cited by 2
Influence of SSRI and SNRI co-prescription on benzodiazepine prescription trajectories
Kinney, K. L., Moreira-Junior, E. D. C., Berro, L. F., Morris, M. C., & Rowlett, J. K. (2025) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2025.100325
“…including psycho-motor impairment, cognitive decline, falls, accidents, and substance use disorders, and chronic use can lead to physical dependence or the development of a use disorder (Guina and Merrill, 2018; Lader, 2011; Licata and Rowlett, 2008; Uzun et al., 2010; Vgontzas et al., 1995).”
Mansour, A. R., Thobias, J. M., Yondu, E., Philipo, E. G., Mikomangwa, W. P., Kilonzi, M., Marealle, A. I., & Mutagonda, R. F. (2025) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/adpp/1404995
Benzodiazepines and the Brain: A Review of Cognitive Impairments and Clinical Implications
Rodrigues, T. J., Sharf, A., Raj, G. V., & C., A. P. K. (2025) · doi:10.38124/ijisrt/25jun499
Cho, J., Lee, K., Woo, S., Park, J., Jo, H., Oh, J., Kim, T. H., Wen, X., Fond, G. B., Boyer, L., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120629
der Linden, L. R. V., Coteur, K., & Tournoy, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29025-1.00003-5
Antoniou, T., McCormack, D., Kitchen, S. A., PAJER, K. A., Gardner, W. P., Lunsky, Y., Penner, M., Tadrous, M., Mamdani, M., Juurlink, D. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26628688
Antoniou, T., McCormack, D., Kitchen, S. A., PAJER, K. A., Gardner, W. P., Lunsky, Y., Penner, M., Tadrous, M., Mamdani, M., Juurlink, D. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26628685
Antoniou, T., McCormack, D., Kitchen, S. A., PAJER, K. A., Gardner, W. P., Lunsky, Y., Penner, M., Tadrous, M., Mamdani, M., Juurlink, D. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26628682
Salazar-Fernández, C., Mawditt, C., Palet, D., Haeger, P. A., & Mella, F. R. (2022) · Figshare · doi:10.6084/m9.figshare.20408389
Fu, Y., Jing, P., Yin, X., Wang, H., Zhang, Y., Liu, X., & Zhou, C. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s585720
Saguin, E. (2023) · theses.fr (ABES) · doi:10.70675/820b81b5zdd45z43a6zb36az8344c91402bd · Cited by 1
Love, E. S. H., Jónsdóttir, F., & Sigurdsson, M. I. (2026) · Scientific Reports · doi:10.1038/s41598-026-49262-z
“and overdose risk 6,8,9 .”
Morandi, A., Fick, D. M., Szczerbinska, K., Ferrara, M. C., Wojszel, Z. B., Dreher, R., Carey, E., Oh, E., Kassidakis, P., Rodrigues, A., et al. (2026) · Delirium · doi:10.56392/001c.161804 · Cited by 1
Chapter 5. Alcohol Use and Use Disorder Among Older Adults
Gopalakrishna, G., Joshi, P., & Patel, N. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551968.lg05
Ayani, N., Matsumoto, Y., Kurokawa, T., Nohara, C., Kobayashi, M., Makino, K., Oya, N., Kitaoka, R., & Narumoto, J. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.109148
Carrazana, E. J., Sirven, J. I., Stern, J. M., Gidal, B. E., Kanner, A. M., & Rabinowicz, A. L. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-01007-w
Production and evaluation of a novel GABA-producing almond yogurt: dietary modulation of stress
Anagha, M., Ramachandran, R., Divyashri, G., & Murthy, T. P. K. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1949462
“Benzodiazepines may be associated with sedation, cognitive and psychomotor impairment, tolerance, dependence, and withdrawal symptoms (4).”
Ненадлежащее использование Z-препаратов: наиболее успешные стратегии преодоления. Обзор
Hmara, N. V., Pitsko, T. P., Ермоленко, В. А., & Шираани, А. Р. (2026) · Психиатрия психотерапия и клиническая психология · doi:10.34883/pi.2026.17.3.008
Probing Melatonin’s Release Pattern from Oral Solid Dosage Forms Using Synthetic Biopolymers
Siamidi, A., Bikiaris, N. D., Protopapa, C., Plyta, M., Saltou, M., Sakellaropoulou, A., & Vlachou, M. (2026) · Polymers · doi:10.3390/polym18202570
“Although conventional sedative and hypnotic agents, including benzodiazepines, are widely used in the management of insomnia, their long-term use is restricted by adverse effects, such as tolerance, dependence, residual daytime sedation, and cognitive impairment [2].”
Metadata
- Authors
- Guina, J., & Merrill, B.
- Affiliations
- Wright State University (US)
- Corresponding author
- Guina, Jeffrey
- ORCID
- Guina, Jeffrey
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2018-01-30
- Volume
- 7
- Issue
- 2
- Pages
- 17
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5852433
- OpenAlex
- W2793017265
- Semantic Scholar
- 81e4137cd04cbc40756500350418397c8843db63
- Cited by
- 253
- References
- 99
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 34 · 2023: 42 · 2022: 32 · 2021: 42 · 2020: 34 · 2019: 25 · 2018: 6
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Journal of Bioresource Management (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepines, sedative-hypnotic drugs, anxiety, insomnia, adverse effects, drug-drug interactions, long-term benzodiazepine use, psychotherapy, sleep hygiene, serotonergic agents, functional recovery, biopsychosocial model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.